BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 20739940)

  • 1. Compound heterozygous PMP22 deletion mutations causing severe Charcot-Marie-Tooth disease type 1.
    Abe A; Nakamura K; Kato M; Numakura C; Honma T; Seiwa C; Shirahata E; Itoh A; Kishikawa Y; Hayasaka K
    J Hum Genet; 2010 Nov; 55(11):771-3. PubMed ID: 20739940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dejerine-Sottas syndrome associated with point mutation in the peripheral myelin protein 22 (PMP22) gene.
    Roa BB; Dyck PJ; Marks HG; Chance PF; Lupski JR
    Nat Genet; 1993 Nov; 5(3):269-73. PubMed ID: 8275092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hereditary neuropathy with liability to pressure palsies: study of six Spanish families].
    Pou Serradell A; Monells J; Téllez MJ; Fossas P; Löfgren A; Meuleman J; Timmerman V; De Jonghe P; Ceuterick C; Martin JJ
    Rev Neurol (Paris); 2002 May; 158(5 Pt 1):579-88. PubMed ID: 12072826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compound heterozygous deletions of PMP22 causing severe Charcot-Marie-Tooth disease of the Dejerine-Sottas disease phenotype.
    Al-Thihli K; Rudkin T; Carson N; Poulin C; Melançon S; Der Kaloustian VM
    Am J Med Genet A; 2008 Sep; 146A(18):2412-6. PubMed ID: 18698610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Many facets of the peripheral myelin protein PMP22 in myelination and disease.
    Naef R; Suter U
    Microsc Res Tech; 1998 Jun; 41(5):359-71. PubMed ID: 9672419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for a recessive PMP22 point mutation in Charcot-Marie-Tooth disease type 1A.
    Roa BB; Garcia CA; Pentao L; Killian JM; Trask BJ; Suter U; Snipes GJ; Ortiz-Lopez R; Shooter EM; Patel PI; Lupski JR
    Nat Genet; 1993 Oct; 5(2):189-94. PubMed ID: 8252046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of multiplex ligation-dependent probe analysis to define a small deletion encompassing PMP22 exons 4 and 5 in hereditary neuropathy with liability to pressure palsies.
    Sutton IJ; Mocroft AP; Lindley VH; Barber RM; Bryon RJ; Winer JB; MacDonald F
    Neuromuscul Disord; 2004 Dec; 14(12):804-9. PubMed ID: 15564036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Four novel point mutations in the PMP22 gene with phenotypes of HNPP and Dejerine-Sottas neuropathy.
    Brožková D; Mazanec R; Rychlý Z; Haberlová J; Böhm J; Staněk J; Plevová P; Lisoňová J; Sabová J; Sakmaryová I; Seeman P
    Muscle Nerve; 2011 Nov; 44(5):819-22. PubMed ID: 22006697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new single-nucleotide deletion of PMP22 in an HNPP family without recurrent palsies.
    Luigetti M; Conte A; Madia F; Mereu ML; Zollino M; Marangi G; Pomponi MG; Liberatore G; Tonali PA; Sabatelli M
    Muscle Nerve; 2008 Aug; 38(2):1060-4. PubMed ID: 18642376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of compound heterozygous mice reveals that the Trembler mutation can behave as a gain-of-function allele.
    Adlkofer K; Naef R; Suter U
    J Neurosci Res; 1997 Sep; 49(6):671-80. PubMed ID: 9335255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular basis of hereditary neuropathies.
    Chance PF
    Phys Med Rehabil Clin N Am; 2001 May; 12(2):277-91. PubMed ID: 11345007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Déjérine-Sottas neuropathy is associated with a de novo PMP22 mutation.
    Valentijn LJ; Ouvrier RA; van den Bosch NH; Bolhuis PA; Baas F; Nicholson GA
    Hum Mutat; 1995; 5(1):76-80. PubMed ID: 7728152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A newly identified Thr99fsX110 mutation in the PMP22 gene associated with an atypical phenotype of the hereditary neuropathy with liability to pressure palsies.
    Moszyńska I; Kabzińska D; Sinkiewicz-Darol E; Kochański A
    Acta Biochim Pol; 2009; 56(4):627-30. PubMed ID: 19830275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular alterations resulting from frameshift mutations in peripheral myelin protein 22: implications for neuropathy severity.
    Johnson JS; Roux KJ; Fletcher BS; Fortun J; Notterpek L
    J Neurosci Res; 2005 Dec; 82(6):743-52. PubMed ID: 16273544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis of haploidy and triploidy based on measurement of gene copy number by real-time PCR.
    Wilke K; Duman B; Horst J
    Hum Mutat; 2000 Nov; 16(5):431-6. PubMed ID: 11058901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A family with a novel frameshift mutation in the PMP22 gene (c.433_434insC) causing a phenotype of hereditary neuropathy with liability to pressure palsies.
    Zéphir H; Stojkovic T; Latour P; Hurtevent JF; Blankaert F; Vermersch P
    Neuromuscul Disord; 2005 Jul; 15(7):493-7. PubMed ID: 15955700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel homozygous mutation of the myelin Po gene producing Dejerine-Sottas disease (hereditary motor and sensory neuropathy type III).
    Ikegami T; Nicholson G; Ikeda H; Ishida A; Johnston H; Wise G; Ouvrier R; Hayasaka K
    Biochem Biophys Res Commun; 1996 May; 222(1):107-10. PubMed ID: 8630052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asian hereditary neuropathy patients with peripheral myelin protein-22 gene aneuploidy.
    Ohnishi A; Li LY; Fukushima Y; Mori T; Mori M; Endo C; Yoshimura T; Sonobe M; Flandermeyer R; Lebo RV
    Am J Med Genet; 1995 Oct; 59(1):51-8. PubMed ID: 8849012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic dosage compensation via co-occurrence of PMP22 duplication and PMP22 deletion.
    Hirt N; Eggermann K; Hyrenbach S; Lambeck J; Busche A; Fischer J; Rudnik-Schöneborn S; Gaspar H
    Neurology; 2015 Apr; 84(15):1605-6. PubMed ID: 25795643
    [No Abstract]   [Full Text] [Related]  

  • 20. Mutations in the peripheral myelin genes and associated genes in inherited peripheral neuropathies.
    Nelis E; Haites N; Van Broeckhoven C
    Hum Mutat; 1999; 13(1):11-28. PubMed ID: 9888385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.